BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18549640)

  • 1. Antibody based conditioning for allogeneic hematopoietic stem cell transplantation.
    Saha A; Blazar BR
    Front Immunol; 2022; 13():1031334. PubMed ID: 36341432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New allogeneic hematopoietic stem cell transplantation method: hematopoietic stem cell transplantation plus thymus transplantation for intractable diseases.
    Hosaka N
    Clin Dev Immunol; 2013; 2013():545621. PubMed ID: 23762092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation.
    Khuat LT; Dave M; Murphy WJ
    Gut Microbes; 2021; 13(1):1966262. PubMed ID: 34455917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation.
    Verstraete E; Baumann C; Rousseau H; Campidelli A; Rubio MT; D'Aveni M
    Leuk Lymphoma; 2024 Feb; 65(2):283-286. PubMed ID: 37990507
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction.
    Wayne AS; Giralt S; Kröger N; Bishop MR
    Biol Blood Marrow Transplant; 2013 Nov; 19(11):1534-6. PubMed ID: 24035783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging concepts in haematopoietic cell transplantation.
    Li HW; Sykes M
    Nat Rev Immunol; 2012 May; 12(6):403-16. PubMed ID: 22627859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new step toward non-genotoxic conditioning prior to hematopoietic stem cell transplantation.
    Cavazzana M; Calvo C
    Mol Ther; 2024 Jun; 32(6):1604-1605. PubMed ID: 38776908
    [No Abstract]   [Full Text] [Related]  

  • 8. Curating evidence for a cure of HIV-1 infection by hematopoietic stem cell transplantation.
    Bone B; Lichterfeld M
    Med; 2023 May; 4(5):285-287. PubMed ID: 37178680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III.
    Barhoom D; Behfar M; Mohseni R; Hamidieh AA
    Hematol Transfus Cell Ther; 2024; 46(3):300-302. PubMed ID: 35256330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
    Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
    Yuan X; Sun ZM; Liu HL; Geng LQ; Wang ZY; Tong J; Yao W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):614-7. PubMed ID: 18549640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
    Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
    Rodriguez R; Parker P; Nademanee A; Smith D; O'Donnell MR; Stein A; Snyder DS; Fung HC; Krishnan AY; Popplewell L; Cohen S; Somlo G; Angelopoulou M; Al-Kadhimi Z; Falk PM; Spielberger R; Kogut N; Sahebi F; Senitzer D; Slovak M; Schriber J; Forman SJ
    Bone Marrow Transplant; 2004 Jun; 33(11):1123-9. PubMed ID: 15064696
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.